Historical salary details - Ms. Kristine Peterson, Independent Director, Enanta Pharmaceuticals Inc
Ms. Kristine Peterson is the Independent Director of Enanta Pharmaceuticals Inc. They also hold 2 other positions in Immunocore Holdings plc - ADR and ArriVent BioPharma Inc..
Ms. Kristine Peterson
Independent Director
$ 326.4 K
Gross Remuneration
-
Current Company
Enanta Pharmaceuticals Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Enanta Pharmaceuticals Inc | Independent Director | 326.4 K | - |
| 2024 | Immunocore Holdings plc - ADR | Independent Director | - | - |
| 2024 | ArriVent BioPharma Inc. | Independent Director | - | - |
| 2023 | Immunocore Holdings plc - ADR | Independent Director | 389.5 K | 592.8 % |
| 2023 | Enanta Pharmaceuticals Inc | Independent Director | 326.4 K | 11.6 % |
| 2023 | Amarin Corp - ADR | Independent Director | - | - |
| 2023 | Enanta Pharmaceuticals Inc | Independent Director | - | - |
| 2022 | Amarin Corp - ADR | Independent Director | 442.0 K | -0.6 % |
| 2022 | Enanta Pharmaceuticals Inc | Independent Director | 292.4 K | 31.4 % |
| 2022 | Immunogen, Inc. | Independent Director | 227.8 K | - |
| 2022 | Immunocore Holdings plc - ADR | Independent Director | 56.2 K | -3.8 % |
| 2021 | Amarin Corp - ADR | Independent Director | 444.5 K | -42.2 % |
| 2021 | Enanta Pharmaceuticals Inc | Independent Director | 222.4 K | -24.4 % |
| 2021 | Immunocore Holdings plc - ADR | Independent Director | 58.4 K | - |
| 2021 | EyePoint Pharmaceuticals Inc | Independent Director | - | - |
| 2020 | Amarin Corp - ADR | Independent Director | 768.7 K | 136.5 % |
| 2020 | Enanta Pharmaceuticals Inc | Independent Director | 294.0 K | -7.2 % |
| 2020 | EyePoint Pharmaceuticals Inc | Independent Director | 104.0 K | 30.8 % |
| 2020 | Immunocore Holdings plc - ADR | Independent Director | - | - |
| 2019 | Amarin Corp - ADR | Independent Director | 325.0 K | 19.3 % |
| 2019 | Enanta Pharmaceuticals Inc | Independent Director | 317.0 K | 54.0 % |
| 2019 | EyePoint Pharmaceuticals Inc | Independent Director | 79.5 K | 200.1 % |
| 2018 | Amarin Corp - ADR | Independent Director | 272.5 K | 67.7 % |
| 2018 | Enanta Pharmaceuticals Inc | Independent Director | 205.8 K | -29.1 % |
| 2018 | EyePoint Pharmaceuticals Inc | Independent Director | 26.5 K | 5868.5 % |
| 2017 | Enanta Pharmaceuticals Inc | Independent Director | 290.3 K | - |
| 2017 | Amarin Corp - ADR | Independent Director | 162.5 K | 1.6 % |
| 2017 | EyePoint Pharmaceuticals Inc | Independent Director | 444.0 | - |
| 2016 | Amarin Corp - ADR | Independent Director | 160.0 K | -45.5 % |
| 2015 | Amarin Corp - ADR | Independent Director | 293.7 K | 91.5 % |
| 2014 | Amarin Corp - ADR | Independent Director | 153.4 K | 31.8 % |
| 2013 | Amarin Corp - ADR | Independent Director | 116.3 K | -71.6 % |
| 2012 | Amarin Corp - ADR | Independent Director | 409.8 K | 1038.3 % |
| 2011 | Amarin Corp - ADR | Independent Director | 36 K | -90.4 % |
| 2010 | Amarin Corp - ADR | Independent Director | 375.2 K | - |